参考文献/References:
[1] Ye Z,Zhang N,Wu C,et al. A metagenomic study of the gut microbiome in Behcet's disease[J].Microbiome,2018,6(1):135. DOI:10.1186/s40168-018-0520-6.
[2] Chen J,Chia N,Kalari KR,et al.Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls[J].Sci Rep,2016,6:28484.DOI:10.1038/srep28484.
[3] Horta-Baas G,Romero-Figueroa MDS,Montiel-Jarquín AJ,et al. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis[J].J Immunol Res,2017,2017:4835189. DOI:10.1155/2017/4835189.
[4] Rosenbaum JT,Silverman GJ.The microbiome and systemic lupus erythematosus[J].N Engl J Med,2018,378(23):2236-2237.DOI:10.1056/NEJMcibr1804368.
[5] Yue B,Luo X,Yu Z,et al. Inflammatory bowel disease:a potential result from the collusion between gut microbiota and mucosal immune system[J].Microorganisms,2019,7(10):pii:E440.DOI:10.3390/microorganisms7100440.
[6] Valitutti F,Cucchiara S,Fasano A.Celiac disease and the microbiome[J].Nutrients,2019,11(10):pii:E2403. DOI:10.3390/nu11102403.
[7] Kugelberg E.Microbiota:diet can protect against type 1 diabetes[J].Nat Rev Immunol,2017,17(5):279.DOI:10.1038/nri.2017.40.
[8] Qin J,Li R,Raes J,et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464(7285):59-65.DOI:10.1038/nature08821.
[9] Davenport ER,Cusanovich DA,Michelini K,et al.Genome-wide association studies of the human gut microbiota[J].PLoS One,2015,10(11):e0140301.DOI:10.1371/journal.pone.0140301.
[10] Patrignani P,Tacconelli S,Bruno A.Gut microbiota, host gene expression, and aging[J].J Clin Gastroenterol,2014,48(Suppl 1):S28-S31.DOI:10.1097/MCG.0000000000000229.
[11] de Carvalho FD,Quick M.Surprising substrate versatility in SLC5A6:Na+-coupled I- transport by the human Na+/multivitamin transporter(hSMVT)[J].J Biol Chem,2011,286(1):131-137.DOI:10.1074/jbc.M110.167197.
[12] Fröhlich E,Wahl R.Microbiota and thyroid interaction in health and disease[J].Trends Endocrinol Metab,2019,30(8):479-490.DOI:10.1016/j.tem.2019.05.008.
[13] Ait-Belgnaoui A,Durand H,Cartier C,et al.Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats[J].Psychoneuroendocrinology,2012,37(11):1885-1895.DOI:10.1016/j.psyneuen.2012.03.024.
[14] Yu J,Koenig RJ.Regulation of hepatocyte thyroxine 5'-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome[J].J Biol Chem,2000,275(49):38296-38301.DOI:10.1074/jbc.M004866200.
[15] Beigneux AP,Moser AH,Shigenaga JK,et al.Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouseliver[J].Am J Physiol Endocrinol Metab,2003,284(1):E228-E236.DOI:10.1152/ajpendo.00155.2002.
[16] Xu M,Iwasaki T,Shimokawa N,et al.The effect of low dose lipopolysaccharide on thyroid hormone-regulated actin cytoskeleton modulation and type 2 iodothyronine deiodinase activity in astrocytes[J].Endocr J,2013,60(11):1221-1230.DOI:10.1507/endocrj.ej13-0294.
[17] Vélez ML,Costamagna E,Kimura ET,et al.Bacterial lipopolysaccharide stimulates the thyrotropin-dependent thyroglobulin gene expressionat the transcriptional level by involving the transcription factors thyroid transcription factor-1 and paired box domain transcription factor 8[J].Endocrinology,2006,147(7):3260-3275.DOI:10.1210/en.2005-0789.
[18] Farzi A,Fröhlich EE,Holzer P.Gut microbiota and the neuroendocrine system[J].Neurotherapeutics,2018,15(1):5-22.DOI:10.1007/s13311-017-0600-5.
[19] Neuman H,Debelius JW,Knight R,et al.Microbial endocrinology: the interplay between the microbiota and the endocrine system[J].FEMS Microbiol Rev,2015,39(4):509-521.DOI:10.1093/femsre/fuu010.
[20] Virili C,Stramazzo I,Santaguida MG,et al.Ulcerative colitis as a novel cause of increased need for levothyroxine[J].Front Endocrinol(Lausanne),2019,10:233.DOI:10.3389/fendo.2019.00233.
[21] Cellini M,Santaguida MG,Gatto I,et al.Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine[J].J Clin Endocrinol Metab,2014,99(8):E1454-E1458.DOI:10.1210/jc.2014-1217.
[22] Zhou L,Li X,Ahmed A,et al.Gut microbe analysis between hyperthyroid and healthy individuals[J].Curr Microbiol,2014,69(5):675-680.DOI:10.1007/s00284-014-0640-6.
[23] Yang M,Sun B,Li J,et al.Alteration of the intestinal flora may participate in the development of Graves' disease:a study conducted among the Han population in southwest China[J].Endocr Connect,2019,8(7):822-828. DOI:10.1530/EC-19-0001.
[24] Masetti G,Moshkelgosha S,Köhling HL,et al.Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease[J].Microbiome,2018,6(1):97.DOI:10.1186/s40168-018-0478-4.
[25] Köhling HL,Plummer SF,Marchesi JR,et al.The microbiota and autoimmunity: their role in thyroid autoimmune diseases[J].Clin Immunol,2017,183:63-74.DOI:10.1016/j.clim.2017.07.001.
[26] Gisbert JP.The recurrence of Helicobacter pylori infection: incidence and variables influencing it.A criticalreview[J].Am J Gastroenterol,2005,100(9):2083-2099.DOI:10.1111/j.1572-0241.2005.50043.
[27] Bassi V,Santinelli C,Iengo A,et al.Identification of a correlation between Helicobacter pylori infection and Graves' disease[J].Helicobacter,2010,15(6):558-562.DOI:10.1111/j.1523-5378.2010.00802.x.
[28] Franceschi F,Satta MA,Mentella MC,et al.Helicobacter pylori infection in patients with Hashimoto's thyroiditis[J].Helicobacter,2004,9(4):369.DOI:10.1111/j.1083-4389.2004.00241.
[29] Guarneri F,Carlotta D,Saraceno G,et al.Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersiniaenterocolitica outer membrane proteins homologous to the human thyrotropin receptor[J].Thyroid,2011,21(11):1283-1284.DOI:10.1089/thy.2010.0364.
[30] Waterhouse M,Hope B,Krause L,et al.Vitamin D and the gut microbiome: a systematic review of in vivo studies[J].Eur J Nutr,2019,58(7):2895-2910. DOI:10.1007/s00394-018-1842-7.
[31] Planck T,Shahida B,Malm J,et al.Vitamin D in Graves disease:levels,correlation with laboratory and clinical parameters, and genetics[J].Eur Thyroid J,2018,7(1):27-33. DOI:10.1159/000484521.
[32] Del Pinto R,Ferri C,Cominelli F.Vitamin D axis in inflammatory bowel diseases: role, current uses and future perspectives[J].Int J Mol Sci,2017,18(11):pii: E2360.DOI:10.3390/ijms18112360.
[33] Gominak SC.Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a "pro-inflammatory" state associated with atherosclerosis and autoimmunity[J].Med Hypotheses,2016,94:103-107.DOI:10.1016/j.mehy.2016.07.007.
[34] Fröhlich E,Wahl R.Thyroid autoimmunity:role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases[J].Front Immunol,2017,8:521.DOI:10.3389/fimmu.2017.00521.
[35] Wichman J,Winther KH,Bonnema SJ,et al.Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis:a systematic review and meta-analysis[J].Thyroid,2016,26(12):1681-1692.DOI: 10.1089/thy.2016.0256.
[36] Duntas LH.The role of iodine and selenium in autoimmune thyroiditis[J].Horm Metab Res,2015,47(10):721-726.DOI:10.1055/s-0035-1559631.
[37] Kudva AK,Shay AE,Prabhu KS.Selenium and inflammatory bowel disease[J].Am J Physiol Gastrointest Liver Physiol,2015,309(2):G71-G77.DOI:10.1152/ajpgi.00379.2014.
[38] Ishaq HM,Mohammad IS,Guo H,et al.Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients[J].Biomed Pharmacother,2017,95:865-874. DOI:10.1016/j.biopha.2017.08.101.
[39] Zhao F,Feng J,Li J,et al.Alterations of the gut microbiota in Hashimoto's thyroiditis patients[J].Thyroid,2018,28(2):175-186. DOI:10.1089/thy.2017.0395.
[40] Furusawa Y,Obata Y,Fukuda S,et al.Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells[J].Nature,2013,504(7480):446-450.DOI:10.1038/nature12721.
[41] Shao S,Yu X,Shen L.Autoimmune thyroid diseases and Th17/Treg lymphocytes[J].Life Sci,2018,192:160-165. DOI:10.1016/j.lfs.2017.11.026.
[42] Atarashi K,Tanoue T,Shima T,et al.Induction of colonic regulatory T cells by indigenous clostridium species[J].Science,2011,331(6015):337-341. DOI:10.1126/science.1198469.
[43] Gaboriau-Routhiau V,Rakotobe S,Lécuyer E,et al.The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cellresponses[J].Immunity,2009,31(4):677-689.DOI:10.1016/j.immuni.2009.08.020.
[44] Zhao J,Chen Y,Zhao Q,et al. Increased circulating Tfh17 and PD-1+Tfh cells are associated with autoantibodies in Hashimoto'sthyroiditis[J].Autoimmunity,2018,51(7):352-359. DOI:10.1080/08916934.2018.1516761.
[45] Teng F,Klinger CN,Felix KM,et al.Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer's patch T follicular helper cells[J].Immunity,2016,44(4):875-888. DOI:10.1016/j.immuni.2016.03.013.
[46] Kiseleva EP,Mikhailopulo KI,Sviridov OV,et al.The role of components of Bifidobacterium and Lactobacillus in pathogenesis and serologicdiagnosis of autoimmune thyroid diseases[J].Benef Microbes,2011,2(2):139-154.DOI:10.3920/BM2010.0011.
[47] Zhou JS,Gill HS.Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis[J].Int J Food Microbiol,2005,103(1):97-104.DOI: 10.1016/j.ijfoodmicro.2004.11.031.
[48] Mori K,Nakagawa Y,Ozaki H. Does the gut microbiota trigger Hashimoto's thyroiditis?[J].Discov Med,2012,14(78):321-326.
[49] Sasso FC,Carbonara O,Torella R,et al.Ultrastructural changes in enterocytes in subjects with Hashimoto's thyroiditis[J].Gut,2004,53(12):1878-1880.
相似文献/References:
[1]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[2]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[3]林天烨,方文军.肠道菌群与代谢性疾病的关系[J].国际内分泌代谢杂志,2014,(04):277.[doi:10.3760/cma.j.issn.1673-4157.2014.04.018]
Lin Tianye*,Fang Wenjun..Relationship between microbiota and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(03):277.[doi:10.3760/cma.j.issn.1673-4157.2014.04.018]
[4]贾媛媛,陈莉丽.Th17细胞与Graves病及桥本甲状腺炎[J].国际内分泌代谢杂志,2014,(05):344.[doi:10.3760/cma.j.issn.1673-4157.2014.05.016]
Jia Yuanyuan,Chen Lili.Relationship between Th17 cells and Graves' disease,Hashimoto's thyroiditis[J].International Journal of Endocrinology and Metabolism,2014,(03):344.[doi:10.3760/cma.j.issn.1673-4157.2014.05.016]
[5]房方,卫红艳,王坤玲,等.硒治疗自身免疫性甲状腺疾病的荟萃分析[J].国际内分泌代谢杂志,2016,36(04):247.[doi:10.3760/cma.j.issn.1673-4157.2016.04.09]
Fang Fang,Wei Hongyan,Wang Kunling,et al.A meta-analysis of selenium in the treatment of autoimmune thyroid diseases[J].International Journal of Endocrinology and Metabolism,2016,36(03):247.[doi:10.3760/cma.j.issn.1673-4157.2016.04.09]
[6]郑仁东,刘超.白细胞介素-6与甲状腺疾病[J].国际内分泌代谢杂志,2016,36(05):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
Zheng Rendong,Liu Chao.Interleukin-6 and thyroid disease[J].International Journal of Endocrinology and Metabolism,2016,36(03):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
[7]郑慧娟,魏璠,魏军平.自噬与自身免疫性甲状腺疾病[J].国际内分泌代谢杂志,2017,37(01):17.[doi:10.3760/cma.j.issn.1673-4157.2017.01.05]
Zheng Huijuan,Wei Fan,Wei Junping..Autophagy and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2017,37(03):17.[doi:10.3760/cma.j.issn.1673-4157.2017.01.05]
[8]浮迎迎,刘超,蔡可英.肠道菌群与甲状腺稳态的关系[J].国际内分泌代谢杂志,2017,37(02):98.[doi:10.3760/cma.j.issn.1673-4157.2017.02.007]
Fu Yingying*,Liu Chao,Cai Keying..Relationship between intestinal bacteria and thyroid homeostasis[J].International Journal of Endocrinology and Metabolism,2017,37(03):98.[doi:10.3760/cma.j.issn.1673-4157.2017.02.007]
[9]狄红杰,刘超.饮食干预对非酒精性脂肪性肝病肠道菌群的影响[J].国际内分泌代谢杂志,2017,37(04):254.
Di Hongjie,Liu Chao..Effects of diet interventions on gut microbiota of nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(03):254.
[10]唐榕 木良善.Akkermansia.muciniphila与代谢性疾病[J].国际内分泌代谢杂志,2018,38(01):36.[doi:10.3760/cma.j.issn.1673-4157.2018.01.010]
Tang Rong*,Mu Liangshan.Akkermansia.muciniphila and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(03):36.[doi:10.3760/cma.j.issn.1673-4157.2018.01.010]